Skip to main content


Figure 1 | Proteome Science

Figure 1

From: Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum

Figure 1

iTRAQ® Ratios for Selected Proteins Identified in Ovarian Cancer and Non-cancer Serum Pools. iTRAQ® ratios from all experiments for proteins that met our criteria for upregulation in at least one experiment (i.e. the ratio of cancer/non-cancer (C/N) was 1.6 or more and the corresponding non-cancer/non-cancer (N/N) ratio was between 0.8 and 1.2). NQ, Not quantified. Gray boxes, not detected or quantified with 1 low confidence peptide. The p-value, EF and number of peptides for each protein, as well as the accession number, are listed in Additional Files Table 1. HAP, haptoglobin; ORM1, orosomucoid 1; LRG, leucine rich alpha-2 glycoprotein 1; AAT, alpha-1 antitrypsin; AACT, alpha-1 antichymotrypsin; ITIH3, inter-alpha globulin inhibitor H3; APOE, apolipoprotein E; SAP, serum amyloid P component; LGALS3BP, galectin-3 binding protein; FGA, fibrinogen-alpha; PRG4, proteoglycan 4; ORM2, orosomucoid 2; LBP1, lipopolysaccharide binding protein 1; ECM1, extracellular matrix protein 1.

Back to article page